deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT04469556

Pancreatic Adenocarcinoma Signature Stratification for Treatment (PASS-01)

Sponsor: Cold Spring Harbor Laboratory

Conditions Advanced Pancreatic Cancer Pancreatic Cancer Metastatic Pancreatic Ductal Adenocarcinoma
Interventions Folfirinox Gemcitabine/nab-paclitaxel
Updated 10 times since 2020 Last updated: Feb 18, 2026 Started: Oct 14, 2020 Primary completion: Mar 5, 2025 Completion: Mar 5, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Advanced Pancreatic Cancer and Pancreatic Cancer Metastatic and is currently completed. Cold Spring Harbor Laboratory leads this study, which shows 10 recorded versions since 2020 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Aug 2020 – ~Dec 2020 · 4 months · monthly snapshotNot Yet Recruiting~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshotRecruiting~Jan 2021 – ~May 2021 · 4 months · monthly snapshotRecruiting~May 2021 – ~Sep 2021 · 4 months · monthly snapshotRecruiting~Sep 2021 – ~May 2022 · 8 months · monthly snapshotRecruiting~May 2022 – ~May 2024 · 24 months · monthly snapshotRecruiting~May 2024 – ~Jul 2024 · 2 months · monthly snapshotActive Not Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotActive Not Recruiting~Sep 2024 – ~Feb 2026 · 17 months · monthly snapshotActive Not Recruiting~Feb 2026 – present · 5 months · monthly snapshotCompleted

Change History

10 versions recorded

  1. Feb 2026 — Present [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  2. Sep 2024 — Feb 2026 [monthly]

    Active Not Recruiting PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE2

  4. May 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  5. May 2022 — May 2024 [monthly]

    Recruiting PHASE2

▶ Show 5 earlier versions

  1. Sep 2021 — May 2022 [monthly]

    Recruiting PHASE2

  2. May 2021 — Sep 2021 [monthly]

    Recruiting PHASE2

  3. Jan 2021 — May 2021 [monthly]

    Recruiting PHASE2

  4. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  5. Aug 2020 — Dec 2020 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cold Spring Harbor Laboratory
  • Dana-Farber Cancer Institute
  • Johns Hopkins University
  • Memorial Sloan Kettering Cancer Center
  • Ontario Institute for Cancer Research
  • Stand Up To Cancer
  • University Health Network, Toronto
Data source: University Health Network, Toronto

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations